Flora P.
- Country
- Italy
- Department
- Complex Structure of Medicine Hemostasis and Thrombosis
Research Overview
- Evaluation of Fitusiran for Bleed Prevention in Patients with Severe Hemophilia A Previously Treated with Emicizumab
- An Adaptive Dose Escalation and Expansion Trial to Evaluate the Safety and Clinical Activity of TGD001 in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura and Other Thrombotic Microangiopathies
- Phase III Randomized Open‑Label Trial of Subcutaneous NXT007 Prophylaxis versus Intravenous Factor VIII Prophylaxis in Patients with Hemophilia A without Inhibitors
Data & Insights
Has run more than one trial at 68 of 129 partner sites.
Specializations
Bleeding Disorders Management
The investigator specializes in treating complex hereditary bleeding disorders, with particular focus on various forms of hemophilia and von Willebrand disease.
- Hemophilia A and B therapeutic interventions
- Von Willebrand Disease treatment strategies
- Pediatric bleeding disorder management
Their expertise extends to both adult and pediatric populations, including newborns up to 12 months of age.
Blood Disorder Therapeutics
The investigator focuses on advancing treatment options for thrombotic thrombocytopenic purpura (TTP) and related blood conditions.
- Immune-mediated TTP treatments
- Novel therapeutic approaches
- Alternative treatment protocols
Their work encompasses both traditional and innovative therapeutic strategies for managing complex blood disorders.
Clinical Innovation
The investigator is involved in evaluating prophylactic treatments and developing new therapeutic approaches for blood disorders.
- Long-term safety assessments
- Joint health outcomes
- Quality of life improvements
Their research includes investigating both subcutaneous and intravenous treatment modalities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.